Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-03-20 07:00 am Purchase | 2024-02-20 | 13G | Biofrontera Inc. BFRI | HIRSCHMAN ORIN | 501,434 9.900% | 501,434 (New Position) | Filing History |
| 2024-02-21 06:01 am Sale | 2024-02-13 | 13G | BrainsWay Ltd. BWAY | HIRSCHMAN ORIN | 682,482 4.100% | -356,046 (-34.28%) | Filing History |
| 2024-02-13 06:34 am Purchase | 2024-02-09 | 13G | Evoke Pharma, Inc. EVOK | HIRSCHMAN ORIN | 70,583 9.990% | 70,583 (New Position) | Filing History |
| 2024-02-07 7:16 pm Sale | 2024-02-07 | 13G | Biodesix, Inc. BDSX | HIRSCHMAN ORIN | 3,408,946 3.800% | -2,159,955 (-38.79%) | Filing History |
| 2024-02-07 7:01 pm Sale | 2024-01-30 | 13G | Cognition Therapeutics, Inc. CGTX | HIRSCHMAN ORIN | 1,448,270 4.800% | -589,583 (-28.93%) | Filing History |
| 2024-02-07 6:58 pm Purchase | 2024-01-23 | 13G | Cellectar Biosciences, Inc. CLRB | HIRSCHMAN ORIN | 2,662,324 8.700% | 747,104 (+39.01%) | Filing History |
| 2024-02-07 6:55 pm Purchase | 2023-12-31 | 13G | LightPath Technologies, Inc. LPTH | HIRSCHMAN ORIN | 3,723,932 9.900% | 144,100 (+4.03%) | Filing History |
| 2024-02-07 6:55 pm Purchase | 2023-12-31 | 13G | Aprea Therapeutics, Inc. APRE | HIRSCHMAN ORIN | 349,300 11.000% | 4,300 (+1.25%) | Filing History |
| 2024-02-07 6:55 pm Purchase | 2023-12-31 | 13G | Apyx Medical Corporation APYX | HIRSCHMAN ORIN | 2,040,540 5.900% | 156,259 (+8.29%) | Filing History |
| 2024-02-07 6:55 pm Purchase | 2023-12-31 | 13G | BK Technologies Corporation BKTI | HIRSCHMAN ORIN | 330,896 9.600% | 330,896 (New Position) | Filing History |
| 2024-02-07 6:55 pm Purchase | 2023-12-31 | 13G | BrainsWay Ltd. BWAY | HIRSCHMAN ORIN | 1,038,528 6.300% | 33,093 (+3.29%) | Filing History |
| 2024-02-07 6:55 pm Purchase | 2023-12-31 | 13G | Coya Therapeutics, Inc. COYA | HIRSCHMAN ORIN | 1,164,372 8.100% | 471,977 (+68.17%) | Filing History |
| 2024-02-07 6:55 pm Purchase | 2023-12-31 | 13G | Electrovaya Inc. ELVA | HIRSCHMAN ORIN | 3,353,308 9.900% | 3,353,308 (New Position) | Filing History |
| 2024-02-07 6:55 pm Purchase | 2024-01-25 | 13G | Elutia Inc. ELUT | HIRSCHMAN ORIN | 1,886,556 9.900% | 17,026 (+0.91%) | Filing History |
| 2024-02-07 6:55 pm Purchase | 2023-12-31 | 13G | KWESST Micro Systems Inc. KWE | HIRSCHMAN ORIN | 55,618 9.900% | 15,618 (+39.04%) | Filing History |
| 2024-02-07 6:55 pm Purchase | 2023-12-31 | 13G | MEDICENNA THERAPEUTICS CORP MDNAF | HIRSCHMAN ORIN | 4,672,075 6.700% | 242,092 (+5.46%) | Filing History |
| 2024-02-07 6:55 pm Purchase | 2024-01-16 | 13G | Myomo, Inc. MYO | HIRSCHMAN ORIN | 2,838,290 9.900% | 298,290 (+11.74%) | Filing History |
| 2024-02-07 6:55 pm Sale | 2023-12-31 | 13G | Red Cat Holdings, Inc. RCAT | HIRSCHMAN ORIN | 5,026,104 7.000% | -250,000 (-4.74%) | Filing History |
| 2024-02-07 6:55 pm Purchase | 2023-12-31 | 13G | scPharmaceuticals Inc. SCPH | HIRSCHMAN ORIN | 3,106,795 8.700% | 556,561 (+21.82%) | Filing History |
| 2024-02-07 6:55 pm Purchase | 2024-01-29 | 13G | SmartKem, Inc. SMTK | HIRSCHMAN ORIN | 136,937 9.900% | 136,937 (New Position) | Filing History |